Published on 11 May 2021
Description:
Achieving a successful launch in a post-COVID-19 world, Alzheimer’s: the search for a cure, Rare diseases: why they can be so difficult to identify
Categories:
Pharmaceutical Market EuropePreview:
31 articles from this collection:
PME May 2021
2 - Communiqué Awards 2021
4 - Pharma Market Europe Communiqué Awards 2021
3 - Comment
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - Coronavirus news
10-11 - Coronavirus news
12 - Darwin’s medicine
12 - Pharma Market Europe Darwin’s medicine
Rohit Khanna - Policy and Public Health - PME May 2021
The technology responses to this pandemic have fallen far short of expectations
14 - Mike Dixon
15 - Stephanie Hall
16-17 - Rare diseases: why they can be so difficult to identify
18-19 - The lessons learned from COVID-19’s impact on oncology trials
18-19 - Empowering patients empowers results
20-21 - Piloting a route to the biosimilars opportunities in Europe
22 - Havas Life Medicom
23 - ICON
24-25 - Alzheimer’s disease: the search for a cure
28-30 - Launch lessons from lockdown
31 - Ashfield Health
32 - Purple Agency
33 - Uptake Strategies
34-36 - Launch engagement
37 - Evida, an AMICULUM agency
38 - The Creative Engagement Group
39 - Triducive
40-41 - Product launches: making the most of your one shot
42-44 - Appointments
45 - Healthcare Comms News
46 - Q&A with Sarah Gordon
47 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
48 - PMEA
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services